Acrylamide

Acrylamide

SCHEMBL7259611

C=CC(N)=O.C=CC(N)=O.[NaH]

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.92
▸ TSHR P16473 4/20 0.92
▸ FGFR4 P22455 1/20 0.92
▸ LMNA P02545 3/20 0.47
▸ TDP1 Q9NUW8 3/20 0.39
▸ OR51E2 Q9H255 1/20 0.39
▸ ACHE P22303 1/20 0.36
▸ MAPK1 P28482 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ PMP22 Q01453 1/20 0.33
▸ LDHA P00338 1/20 0.31
▸ LDHB P07195 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylamide SCHEMBL168797 1.00 — —
Acrylamide SCHEMBL28187964 1.00 — —
Acrylamide SCHEMBL28177574 0.96 — —
Acrylamide SCHEMBL170034 0.96 TSHR (1.00) ALDH1A1TSHRFGFR4LMNATDP1
Acrylamide SCHEMBL1332254 0.96 — —
Acrylamide SCHEMBL183292 0.96 TSHR (1.00) ALDH1A1TSHRFGFR4LMNATDP1
Acrylamide SCHEMBL1332245 0.96 — —
Acrylamide SCHEMBL3051 0.96 — —
Acrylamide SCHEMBL22412946 0.92 — —
Acrylamide SCHEMBL1225106 0.92 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102093519-A Preparation method of mud-resistant type polycarboxylate superplasticizer JIANGSU HUIDI BUILDING MATERIAL CO LTD 2011-06-15 — — CN disclosed
EP-1276507-A2 HIGH AFFINITY PEPTIDE-CONTAINING NANOPARTICLES Alnis Biosciences, Inc. (US) 2003-01-22 — — EP disclosed
WO-2001078786-A2 HIGH AFFINITY PEPTIDE-CONTAINING NANOPARTICLES ALNIS BIOSCIENCES, INC. (US) 2001-10-25 — — WO disclosed
Send feedback